Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial

BACKGROUND: SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials o...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS Negl Trop Dis
Main Authors: Wasunna, Monique, Njenga, Simon, Balasegaram, Manica, Alexander, Neal, Omollo, Raymond, Edwards, Tansy, Dorlo, Thomas P. C., Musa, Brima, Ali, Mohammed Hassan Sharaf, Elamin, Mohammed Yasein, Kirigi, George, Juma, Rashid, Kip, Anke E., Schoone, Gerard J., Hailu, Asrat, Olobo, Joseph, Ellis, Sally, Kimutai, Robert, Wells, Susan, Khalil, Eltahir Awad Gasim, Strub Wourgaft, Nathalie, Alves, Fabiana, Musa, Ahmed
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2016
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5023160/
https://ncbi.nlm.nih.gov/pubmed/27627654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004880
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים